Boehringer Ingelheim’s Spiolto Respimat Improves Quality of Life in COPD Patients
COPD, News
Boehringer Ingelheim recently announced new positive data on the Phase IIIb OTEMTO® 1 and 2 trials (NCT01964352 and NCT02006732) on Spiolto® Respimat® (tiotropium plus olodaterol) in patients with chronic obstructive ... Read more